These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38516785)

  • 41. Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
    Osborne SR; Alston LV; Bolton KA; Whelan J; Reeve E; Wong Shee A; Browne J; Walker T; Versace VL; Allender S; Nichols M; Backholer K; Goodwin N; Lewis S; Dalton H; Prael G; Curtin M; Brooks R; Verdon S; Crockett J; Hodgins G; Walsh S; Lyle DM; Thompson SC; Browne LJ; Knight S; Pit SW; Jones M; Gillam MH; Leach MJ; Gonzalez-Chica DA; Muyambi K; Eshetie T; Tran K; May E; Lieschke G; Parker V; Smith A; Hayes C; Dunlop AJ; Rajappa H; White R; Oakley P; Holliday S
    Med J Aust; 2020 Dec; 213 Suppl 11():S3-S32.e1. PubMed ID: 33314144
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Screening tests for active pulmonary tuberculosis in children.
    Vonasek B; Ness T; Takwoingi Y; Kay AW; van Wyk SS; Ouellette L; Marais BJ; Steingart KR; Mandalakas AM
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD013693. PubMed ID: 34180536
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.
    Zenner D; Hafezi H; Potter J; Capone S; Matteelli A
    Int J Tuberc Lung Dis; 2017 Sep; 21(9):965-976. PubMed ID: 28826445
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tuberculosis screening for long-term care: a cost-effectiveness analysis.
    Verma G; Chuck AW; Jacobs P
    Int J Tuberc Lung Dis; 2013 Sep; 17(9):1170-7. PubMed ID: 23928166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Community-based active case-finding interventions for tuberculosis: a systematic review.
    Burke RM; Nliwasa M; Feasey HRA; Chaisson LH; Golub JE; Naufal F; Shapiro AE; Ruperez M; Telisinghe L; Ayles H; Corbett EL; MacPherson P
    Lancet Public Health; 2021 May; 6(5):e283-e299. PubMed ID: 33765456
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
    Haukaas FS; Arnesen TM; Winje BA; Aas E
    Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of cost-effectiveness of tuberculosis screening of close contacts and foreign-born populations.
    Dasgupta K; Schwartzman K; Marchand R; Tennenbaum TN; Brassard P; Menzies D
    Am J Respir Crit Care Med; 2000 Dec; 162(6):2079-86. PubMed ID: 11112118
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A Systematic Review of Studies Evaluating the Cost Utility of Screening High-Risk Populations for Latent Tuberculosis Infection.
    Campbell JR; Sasitharan T; Marra F
    Appl Health Econ Health Policy; 2015 Aug; 13(4):325-40. PubMed ID: 26129810
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of interferon-gamma release assay testing for the treatment of latent tuberculosis.
    Diel R; Wrighton-Smith P; Zellweger JP
    Eur Respir J; 2007 Aug; 30(2):321-32. PubMed ID: 17504793
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon-gamma release assay for tuberculosis screening of solid-organ transplant recipients is cost-effective.
    Kowada A
    J Infect; 2019 Jan; 78(1):58-65. PubMed ID: 30009853
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Active case finding for tuberculosis among high-risk groups in low-incidence countries.
    Zenner D; Southern J; van Hest R; DeVries G; Stagg HR; Antoine D; Abubakar I
    Int J Tuberc Lung Dis; 2013 May; 17(5):573-82. PubMed ID: 23575321
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nationwide surveillance algorithms for tuberculosis among immigrant workers from highly endemic countries following pre-entry screening in Taiwan.
    Kuan MM
    BMC Public Health; 2018 Oct; 18(1):1151. PubMed ID: 30285697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Active case finding and treatment adherence in risk groups in the tuberculosis pre-elimination era.
    Gupta RK; Lipman M; Story A; Hayward A; de Vries G; van Hest R; Erkens C; Rangaka MX; Abubakar I
    Int J Tuberc Lung Dis; 2018 May; 22(5):479-487. PubMed ID: 29663951
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.
    Campbell JR; Johnston JC; Cook VJ; Sadatsafavi M; Elwood RK; Marra F
    Emerg Infect Dis; 2019 Apr; 25(4):661-671. PubMed ID: 30882302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.
    Abubakar I; Drobniewski F; Southern J; Sitch AJ; Jackson C; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Lynn W; Burgess H; Mann B; Imran A; Sridhar S; Tsou CY; Nikolayevskyy V; Rees-Roberts M; Whitworth H; Kon OM; Haldar P; Kunst H; Anderson S; Hayward A; Watson JM; Milburn H; Lalvani A;
    Lancet Infect Dis; 2018 Oct; 18(10):1077-1087. PubMed ID: 30174209
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tuberculosis screening in outpatient healthcare workers: lessons from a high-income, low TB burden country.
    Di Bella S; Siroka A; Antonello RM; Zignol M; Maschio M; Tominz R; Cirillo D; Migliori GB; Confalonieri M; Raviglione M; Luzzati R
    Int J Tuberc Lung Dis; 2019 Sep; 23(9):1024-1028. PubMed ID: 31615611
    [No Abstract]   [Full Text] [Related]  

  • 57. Cost effectiveness of interferon-γ release assay for TB screening of HIV positive pregnant women in low TB incidence countries.
    Kowada A
    J Infect; 2014 Jan; 68(1):32-42. PubMed ID: 23973660
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of screening high-risk HIV-positive men who have sex with men (MSM) and HIV-positive women for anal cancer.
    Czoski-Murray C; Karnon J; Jones R; Smith K; Kinghorn G
    Health Technol Assess; 2010 Nov; 14(53):iii-iv, ix-x, 1-101. PubMed ID: 21083999
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of latent tuberculosis infection in HIV infected persons.
    Akolo C; Adetifa I; Shepperd S; Volmink J
    Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD000171. PubMed ID: 20091503
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The diagnostic performance of novel skin-based in-vivo tests for tuberculosis infection compared with purified protein derivative tuberculin skin tests and blood-based in vitro interferon-γ release assays: a systematic review and meta-analysis.
    Krutikov M; Faust L; Nikolayevskyy V; Hamada Y; Gupta RK; Cirillo D; Mateelli A; Korobitsyn A; Denkinger CM; Rangaka MX
    Lancet Infect Dis; 2022 Feb; 22(2):250-264. PubMed ID: 34606768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.